ArticleDrug and alcohol review2026
Associations Between Pain Severity and Opioid Agonist Treatment Among People With Drug Injection Experience in Australia.
Article in Drug and alcohol review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionPain is highly prevalent among people with opioid use disorder (OUD), yet it is often undertreated. Whether opioid agonist treatment (OAT) improves pain outcomes is unknown among this target population. This research aimed to explore associations between pain severity and current OAT status in a longitudinal cohort of people who inject drugs.
methodsData were drawn from the Melbourne Injecting Drug User Cohort Study (SuperMIX), comprising individuals with a drug injection history recruited from areas across Greater Melbourne and Geelong, Australia, between 2008 and 2024. Eligible participants were adults who reported ever being in OAT for at least one time point. Participants were classified into four groups based on their self-reported pain level (from none to severe). Multilevel ordinal logistic regression with a participant-level random intercept examined the association between pain severity and current OAT status, comparing current OAT (methadone or buprenorphine) with no current OAT as the reference category. Current OAT status was treated as a time-varying exposure, with methadone and buprenorphine examined separately in sensitivity analyses. Models were adjusted for demographic and clinical characteristics and substance use history.
resultsA total of 1328 participants were eligible for inclusion. At baseline, most were male (67.7%), on government income support (81.9%), and had pain at any level in the past 4 weeks (66.0%), with a mean age of 36.7 (SD 10.6) years. No association between pain severity and current OAT status was observed, while several other factors associated with higher pain severity were identified, such as older age, poorer overall health and the use of other opioids. DISCUSSION AND
conclusionsWhile OAT status was not associated with pain severity in this study, several other factors associated with higher pain severity were identified. These findings highlight the multifactorial nature of pain in this population and the importance of considering broader physical and emotional health when managing pain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.